ATE433331T1 - Kontrastmittel für die magnetresonanztomographie und entsprechende verfahren - Google Patents

Kontrastmittel für die magnetresonanztomographie und entsprechende verfahren

Info

Publication number
ATE433331T1
ATE433331T1 AT03716374T AT03716374T ATE433331T1 AT E433331 T1 ATE433331 T1 AT E433331T1 AT 03716374 T AT03716374 T AT 03716374T AT 03716374 T AT03716374 T AT 03716374T AT E433331 T1 ATE433331 T1 AT E433331T1
Authority
AT
Austria
Prior art keywords
contrast agents
magnetic resonance
resonance tomography
corresponding procedures
provides methods
Prior art date
Application number
AT03716374T
Other languages
English (en)
Inventor
Eric Ahrens
Original Assignee
Univ Carnegie Mellon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Carnegie Mellon filed Critical Univ Carnegie Mellon
Application granted granted Critical
Publication of ATE433331T1 publication Critical patent/ATE433331T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03716374T 2002-03-07 2003-03-07 Kontrastmittel für die magnetresonanztomographie und entsprechende verfahren ATE433331T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36316302P 2002-03-07 2002-03-07
PCT/US2003/007018 WO2003075747A2 (en) 2002-03-07 2003-03-07 Contrast agents for magnetic resonance imaging and methods related thereto

Publications (1)

Publication Number Publication Date
ATE433331T1 true ATE433331T1 (de) 2009-06-15

Family

ID=27805266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03716374T ATE433331T1 (de) 2002-03-07 2003-03-07 Kontrastmittel für die magnetresonanztomographie und entsprechende verfahren

Country Status (11)

Country Link
US (1) US8084017B2 (de)
EP (1) EP1487499B1 (de)
JP (2) JP2005518816A (de)
AT (1) ATE433331T1 (de)
AU (2) AU2003220084B2 (de)
CA (1) CA2478120C (de)
DE (1) DE60327927D1 (de)
DK (1) DK1487499T3 (de)
ES (1) ES2327912T3 (de)
IL (2) IL163937A0 (de)
WO (1) WO2003075747A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003207508A (ja) * 2002-01-09 2003-07-25 Japan Science & Technology Corp 遺伝子発現のモニタリング方法
US7998704B2 (en) * 2002-03-07 2011-08-16 Carnegie Mellon University Methods for magnetic resonance imaging
WO2003075747A2 (en) * 2002-03-07 2003-09-18 Carnegie Mellon University Contrast agents for magnetic resonance imaging and methods related thereto
EP1830902A2 (de) * 2004-12-30 2007-09-12 Cinvention Ag Kombination aus einem mittel, das ein signal abgibt, implantatmaterial und arzeimittel
US8182444B2 (en) * 2005-11-04 2012-05-22 Medrad, Inc. Delivery of agents such as cells to tissue
US7713232B2 (en) * 2005-11-04 2010-05-11 Medrad, Inc. System for washing and processing of cells for delivery thereof to tissue
WO2007092740A2 (en) * 2006-02-07 2007-08-16 The Regents Of The University Of California Method and system for the amplification of nuclear magnetic resonance imaging
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
DE102007015598A1 (de) 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
US20110135575A1 (en) * 2007-08-28 2011-06-09 Massachusetts Institute Of Technology Metalloprotein mri contrast agents and related methods
JP5325427B2 (ja) * 2008-02-20 2013-10-23 株式会社Ｉｈｉ 磁性を有する薬剤
KR101029765B1 (ko) * 2008-06-12 2011-04-19 서울대학교병원 페리틴 유전자를 포함하는 렌티바이러스 벡터 및 그의 용도
GB0812191D0 (en) * 2008-07-03 2008-08-13 Greater Glasgow Health Board Modified cells and methods of monitoring their viability
AR084020A1 (es) 2010-11-30 2013-04-17 Genentech Inc Anticuerpos para el receptor de la barrera hematoencefalica de baja afinidad y sus usos
US9387264B2 (en) 2012-04-05 2016-07-12 Yeda Research And Development Co. Ltd. Reporter genes for magnetic resonance imaging and methods of use thereof
CA2921493A1 (en) * 2012-08-21 2014-02-27 Brown University Ferritin-based tumor targeting agent, and imaging and treatment methods
EP2783703A1 (de) 2013-03-25 2014-10-01 B. Braun Melsungen AG Semi-Fluorkohlenstoff-Verbindung mit Kontrastmittel
CN106324008B (zh) * 2015-07-02 2018-10-16 中国石油天然气股份有限公司 核磁共振测井波谱的校正方法
CN106680509A (zh) * 2016-12-27 2017-05-17 山东爱维德生物科技有限公司 铁蛋白定量检测试剂盒、其制备及使用方法
IL295143B2 (en) * 2020-02-13 2026-02-01 Hoffmann La Roche A method for determining the loading state of AAV particles using nuclear magnetic resonance relaxometry
GB202004892D0 (en) * 2020-04-02 2020-05-20 Governing Council Of The Univ Of Toronto Ferritin for cellular tracking utilizing T1-weighted MRI

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US6232295B1 (en) * 1994-10-12 2001-05-15 Jon Faiz Kayyem Cell-specific contrast agent and gene delivery vehicles
US20020025296A1 (en) * 1994-10-21 2002-02-28 Knaus Edward E. Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy
US5707605A (en) * 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US6180389B1 (en) 1997-01-03 2001-01-30 The Research And Development Institute, Inc. Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules
WO1998033809A1 (en) 1997-01-31 1998-08-06 The General Hospital Corporation Compositions and methods for imaging gene expression
CA2309904A1 (en) * 1997-11-14 1999-05-27 Cedars-Sinai Medical Center Transfection and transfer of male germ cells for generation of transgenic species
US6511967B1 (en) 1999-04-23 2003-01-28 The General Hospital Corporation Use of an internalizing transferrin receptor to image transgene expression
US6495355B1 (en) 1999-06-22 2002-12-17 The Board Of Trustees Of The Leland Stanford Junior University Red-shifted luciferase
US6812339B1 (en) 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2003075747A2 (en) * 2002-03-07 2003-09-18 Carnegie Mellon University Contrast agents for magnetic resonance imaging and methods related thereto
EP1504037B1 (de) * 2002-05-10 2009-12-30 New Century Pharmaceuticals, Inc. Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen

Also Published As

Publication number Publication date
AU2008249217A1 (en) 2008-12-18
IL163937A0 (en) 2005-12-18
ES2327912T3 (es) 2009-11-05
AU2008249217B2 (en) 2012-03-08
CA2478120A1 (en) 2003-09-18
EP1487499B1 (de) 2009-06-10
EP1487499A4 (de) 2005-11-16
AU2003220084B2 (en) 2008-08-28
CA2478120C (en) 2016-01-12
EP1487499A2 (de) 2004-12-22
WO2003075747A3 (en) 2004-03-25
JP2011092208A (ja) 2011-05-12
US8084017B2 (en) 2011-12-27
JP2005518816A (ja) 2005-06-30
DK1487499T3 (da) 2009-07-20
DE60327927D1 (de) 2009-07-23
AU2003220084A1 (en) 2003-09-22
IL163937A (en) 2010-11-30
WO2003075747A2 (en) 2003-09-18
US20030219385A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
ATE433331T1 (de) Kontrastmittel für die magnetresonanztomographie und entsprechende verfahren
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
ATE510838T1 (de) Verfahren zur herstellung von 2-methyl-1-(2- methylpropyl)-1h-imidazoä4,5-cüä1,5ünaphthyridi - 4-amin
EA200701299A1 (ru) Производные стильбена и их применение для связывания и визуализации амилоидных бляшек
NO2018030I1 (no) Florbetapir (18F)
DK1472541T3 (da) Afbildningsmidler og metoder til at afbilde NAALADase og PSMA
DE602004029412D1 (de) Fahrerhaus für eine Erdbewegungsmaschine
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
DE60140286D1 (de) Legiertes Stahlpulver für pulvermetallurgisches Verfahren
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
UY29233A1 (es) Procedimiento para preparar derivados condensados de piperazin-2-ona
WO2006099516A3 (en) Methods for magnetic resonance imaging
DE60223176D1 (de) Metallkomplexverbindungen
DE602004024894D1 (de) Messverfahren für dreidimensionale form und messvorrichtung dafür
ATE299139T1 (de) Ccr5 antagonisten verwendbar für die behandlung von aids
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
ATE365786T1 (de) Geschmackszutaten für kühlende zubereitungen
DE50110487D1 (de) Phasenkorrekturverfahren für die MR-Echtzeitbildgebung
EP1265073A3 (de) Verfahren zum Nachweis von der Plasmakonzentration von freien Arzneimitteln
DE60311142D1 (de) Verfahren für die magnetische resonanzbildgebung
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
WO2004037210A3 (en) Functional mri agents for cancer imaging
DE60333112D1 (de) 2-heterosubstituierte 3-aryl-4-h-1-benzopyran-4-one als neue therapeutika bei brustkrebs
DE602004031736D1 (de) Verbessertes verfahren für festphasensynthese
SE0202608D0 (sv) New sequences

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1487499

Country of ref document: EP